| Tumor necrosis factor: still a promising agent |
| E Frei, 3d and D Spriggs |
|
JCO Mar 1 1989: 291–294.
[PDF]
|
 |
| Male fertility following cancer chemotherapy |
| RL Schilsky |
|
JCO Mar 1 1989: 295–297.
[PDF]
|
|
|
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer |
| |
AA Jakubowski, ES Casper, JL Gabrilove, MA Templeton, SA Sherwin, and HF Oettgen |
| |
JCO Mar 1 1989: 298–303.
[Abstract]
[PDF]
|
|
|
Male gonadal function after chemotherapy for solid tumors in childhood |
| |
F Aubier, F Flamant, R Brauner, JM Caillaud, JM Chaussain, and J Lemerle |
| |
JCO Mar 1 1989: 304–309.
[Abstract]
[PDF]
|
|
|
Bilateral Wilms' tumor: long-term survival and some epidemiological features |
| |
MJ Coppes, J de Kraker, PJ van Dijken, HJ Perry, JF Delemarre, MF Tournade, J Lemerle, and PA Voute |
| |
JCO Mar 1 1989: 310–315.
[Abstract]
[PDF]
|
|
|
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group |
| |
DR Miller, SL Leikin, VC Albo, H Sather, and GD Hammond |
| |
JCO Mar 1 1989: 316–325.
[Abstract]
[PDF]
|
|
|
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission |
| |
MS Tallman, KJ Kopecky, D Amos, S Dahlberg, JS Hewlett, JC Files, CA Coltman, ED Thomas, and FR Appelbaum |
| |
JCO Mar 1 1989: 326–337.
[Abstract]
[PDF]
|
|
|
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis |
| |
M Bregni, S Siena, A Neri, R Bassan, T Barbui, D Delia, G Bonadonna, R Dalla Favera, and AM Gianni |
| |
JCO Mar 1 1989: 338–343.
[Abstract]
[PDF]
|
|
|
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients |
| |
D Spiegelman, LH Maurer, JH Ware, MC Perry, AP Chahinian, R Comis, W Eaton, B Zimmer, and M Green |
| |
JCO Mar 1 1989: 344–354.
[Abstract]
[PDF]
|
|
|
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma |
| |
PR Rosen, S Groshen, PE Saigo, DW Kinne, and S Hellman |
| |
JCO Mar 1 1989: 355–366.
[Abstract]
[PDF]
|
|
|
Breast conservation versus mastectomy: distress sequelae as a function of choice |
| |
SM Levy, RB Herberman, JK Lee, ME Lippman, and T d'Angelo |
| |
JCO Mar 1 1989: 367–375.
[Abstract]
[PDF]
|
|
|
Treatment of intraductal carcinoma with limited surgery: long-term follow-up |
| |
WJ Gallagher, FC Koerner, and WC Wood |
| |
JCO Mar 1 1989: 376–380.
[Abstract]
[PDF]
|
|
|
Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin |
| |
AD Turnbull, J Guerra, and HF Starnes |
| |
JCO Mar 1 1989: 381–386.
[Abstract]
[PDF]
|
|
|
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol |
| |
LH Einhorn, SD Williams, PJ Loehrer, R Birch, R Drasga, G Omura, and FA Greco |
| |
JCO Mar 1 1989: 387–391.
[Abstract]
[PDF]
|
|
|
Homoharringtonine-induced hyperglycemia |
| |
RK Sylvester, M Lobell, W Ogden, and JA Stewart |
| |
JCO Mar 1 1989: 392–395.
[Abstract]
[PDF]
|
|
|
Chronic daily administration of oral etoposide--a phase I trial |
| |
JD Hainsworth, DH Johnson, SR Frazier, and FA Greco |
| |
JCO Mar 1 1989: 396–401.
[Abstract]
[PDF]
|
|
| Activity of coumarin and cimetidine in metastatic renal cell carcinoma |
| AP Venook, Y Davenport, and A Tseng, Jr |
|
JCO Mar 1 1989: 402–403.
[PDF]
|
|
| Prognostic factors related to response to chemotherapy in metastatic breast cancer |
|
|
JCO Mar 1 1989: 403–404.
[PDF]
|
|
